Plenary I: New Frontiers in HCT & Cell and Gene Therapy

Speaker(s)

• 

  Christian Gocke, MD, PhD

  Assistant Professor of Oncology
  Johns Hopkins University
  Baltimore, Maryland
• 

  Steven Devine, MD

  Chief Medical Officer
  NMDP
  Minneapolis, MN
• 

  David Wald, MD PhD

  Professor
  Case Western Reserve University
  Cleveland, Ohio

Moderator(s)

• 

  Medhat Askar, MD, PhD

  Associate Vice President For Clinical Affairs | Professor of Immunology
  Qatar University
  Doha, Ad Dawhah, Qatar
• 

  Maria Bettinotti, PhD

  Director, Immunogenetics Laboratory
  Johns Hopkins University
  Baltimore, MD

Therapies that harness the immune system's ability to target and destroy cancer cells revolutionized the treatment of hematologic malignances and continue to evolve at an accelerated pace. In this plenary session, experts in Hematopoietic Cell Transplantation (HCT) and chimeric antigen receptor (CAR) T cells will inform us on advances that enable the use of these cellular therapies on a growing number of patients. We will learn how the expansion of the donor pool with mismatched unrelated donors, the use of personalized medicine to find donors for highly sensitized patients, and the accelerated production of CAR T cells open the pathway for patients who in the past had no access to these life-saving treatments.

To learn more please click here.

Therapies that harness the immune system's ability to target and destroy cancer cells revolutionized the treatment of hematologic malignances and continue to evolve at an accelerated pace. In this plenary session, experts in Hematopoietic Cell Transplantation (HCT) and chimeric antigen receptor (CAR) T cells will inform us on advances that enable the use of these cellular therapies on a growing number of patients. We will learn how the expansion of the donor pool with mismatched unrelated donors, the use of personalized medicine to find donors for highly sensitized patients, and the accelerated production of CAR T cells open the pathway for patients who in the past had no access to these life-saving treatments.

Presentations:

• 10:30 AM - 11:00 AM US EDT

  Navigating Hematopoietic Stem Cell Transplantation in the Sensitized Patient
  

  Speaker: Christian B. Gocke, MD, PhD – Johns Hopkins University
• 11:00 AM - 11:30 AM US EDT

  Expanding Access to Transplantation Using HLA Mismatched Unrelated Donors
  

  Speaker: Steven Devine, MD – NMDP
• 11:30 AM - 12:00 PM US EDT

  Recent Advances in CAR-T Cell Therapy
  

  Speaker: David Wald, MD PhD – Case Western Reserve University